This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer, for the supply of SELEXIPAG (UPTRAVI) TABS, a pharmaceutical product. The contract has a ceiling value of $712,831.92 and a period of performance through February 8, 2026.
The award is associated with Actelion's larger federal contract vehicles, including a $219,108,390 multiple-award Federal Supply Schedule (FSS-61-IB) contract with the VA, as well as two Blanket Purchase Agreements (BPAs) valued at $118.5 million and $83.5 million, respectively. These contracts facilitate streamlined procurement of Actelion's specialized pharmaceutical products for the VA, Federal Bureau of Prisons, and other eligible federal beneficiaries.
The contract does not utilize a small business set-aside designation, indicating Actelion operates as a large pharmaceutical manufacturer serving federal healthcare institutions. The VA's Veterans Integrated Service Network 20 is the funding agency for this delivery order.
Generated 2/8/25, 9:02 AM